Latest News
Bliss GVS Pharma Limited
- We Ran A Stock Scan For Earnings Growth And Bliss GVS Pharma (NSE:BLISSGVS) Passed With Ease
- Bliss GVS Pharma (NSE:BLISSGVS): Why Did It Extend the Window for Physical Share Transfer Re-Lodgement?
- Bliss GVS Pharma Ltd is Rated Buy
- Anupam Rasayan deepens pharma push with Bliss GVS buy, eyes ₹4,000 crore platform
- Bliss GVS Pharma board approves ESOP 2026 plans for employees
- How Anupam Rasayan plans to double Bliss GVS Pharma's rev in three years
- Anupam Rasayan takes control of Bliss GVS in ₹1,750 crore bet on pharma scale-up
- Surat-based Anupam Rasayan completes ₹1,750-cr acquisition of 48.2% in Bliss GVS Pharma
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platform
- Anupam Rasayan Acquires Bliss GVS Pharma for Rs 1,750 Cr
- Anupam Rasayan completes Rs. 1,750 crore acquisition of Bliss GVS Pharma to build global platform
- Price Band Hitters, September 28, 2026 at 12:00 PM IST: Bliss GVS Pharma, Sunflag, Lalithaa Jewellery, Rehtan TMT
Headlines from the last 30 days, linking to the original publishers. See all market news →